6-MERCAPTOPURINE PLASMA-LEVELS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - RELATION TO RELAPSE RISK AND MYELOTOXICITY

被引：44
|
作者：
HAYDER, S
LAFOLIE, P
BJORK, O
PETERSON, C
机构：
[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,POB 60500,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,DEPT PEDIAT,S-10401 STOCKHOLM 60,SWEDEN
来源：
THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 06期
关键词：
D O I：
10.1097/00007691-198911000-00001
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：617 / 622
页数：6
相关论文
共 50 条
  • [31] SPEED OF RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    BAREFORD, D
    BAILEY, CC
    ROBINSON, EAE
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1985, 35 (03): : 329 - 332
  • [32] CNS RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HABEL, A
    HUGHES, G
    DURRANT, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (04) : 737 - 738
  • [33] TESTICULAR RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    DIGILIO, G
    MULTARI, G
    BALLATI, G
    LORENZINI, F
    WERNER, B
    BONAMICO, M
    STEGAGNO, G
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1983, 9 (04): : 375 - 380
  • [34] Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?
    Mahoney, DH
    PEDIATRIC BLOOD & CANCER, 2006, 46 (05) : 660 - 661
  • [35] PATTERN OF 6-MERCAPTOPURINE URINARY-EXCRETION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - URINARY ASSAYS AS A MEASURE OF DRUG COMPLIANCE
    MACDOUGALL, LG
    MCELLIOGOTT, SE
    ROSS, E
    GREEFF, MC
    POOLE, JE
    THERAPEUTIC DRUG MONITORING, 1992, 14 (05) : 371 - 375
  • [36] RECTAL BIOAVAILABILITY OF 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - PARTIAL AVOIDANCE OF 1ST-PASS METABOLISM
    KATO, Y
    MATSUSHITA, T
    UCHIDA, H
    EGI, S
    YOKOYAMA, T
    MOHRI, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (06) : 619 - 622
  • [37] Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia
    Filhon, B.
    Dumesnil, C.
    Van Dreden, P.
    Schneider, P.
    Vasse, M.
    Vannier, J. P.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1164 - 1166
  • [38] Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
    Larsen, Rikke Hebo
    Hjalgrim, Lisa Lyngsie
    Grell, Kathrine
    Kristensen, Kim
    Pedersen, Line Gerner
    Brunner, Emilie Damgaard
    Als-Nielsen, Bodil
    Schmiegelow, Kjeld
    Nersting, Jacob
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 25 - 32
  • [39] 6-MERCAPTOPURINE DOSAGE REDUCTION AND TPMT POLYMORPHISMS IN THE TREATMENT OF CHILDREN ACUTE LYMPHOBLASTIC LEUKEMIA
    Ferreira Baptista, A.
    Coucelo, M.
    Garrido, T.
    Mendes, M. J.
    Marini, S.
    Saturnino, H.
    Silva, S.
    Brito, M. J.
    Benedito, M.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2014, 99 : 277 - 277
  • [40] Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia
    Minu Singh
    Divya Bhaskar
    Prateek Bhatia
    Rozy Thakur
    Pankaj Sharma
    Deepak Bansal
    Richa Jain
    Amita Trehan
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 51 - 56
12345